×
About 43,985 results

ALLMedicine™ Acute Myeloid Leukemia Center

Research & Reviews  13,106 results

Characterization of a multidisciplinary team's role in hospital discharge for patients ...
https://doi.org/10.1007/s00520-023-07664-z
Supportive Care in Cancer : Official Journal of the Multi... Pervitsky V, Guglielmo J et. al.

Mar 22nd, 2023 - Venetoclax combined with a hypomethylating agent (HMA) has become the standard of care for elderly/unfit patients with newly diagnosed acute myeloid leukemia (AML). This study is aimed at characterizing the impact of an interdisciplinary team on t...

Clinical characteristics and outcomes of children with newly diagnosed acute myeloid le...
https://doi.org/10.1002/cncr.34751
Cancer Christakopoulos GE, Walker KN et. al.

Mar 22nd, 2023 - Hyperleukocytosis in patients with acute myeloid leukemia (AML) has been associated with worse outcomes. For cytoreduction, leukapheresis has been used but its clinical utility is unknown, and low-dose cytarabine (LD-cytarabine) is used as an alte...

Lycorine induces apoptosis of acute myeloid leukemia cells and inhibits triglyceride pr...
https://doi.org/10.1007/s00277-023-05169-7
Annals of Hematology; Liang X, Fu W et. al.

Mar 22nd, 2023 - Acute myeloid leukemia (AML) is the most common hematopoietic malignancy with abnormal lipid metabolism. However, currently available information on the involvement of the alterations in lipid metabolism in AML development is limited. In this stud...

Cryo-EM analyses of KIT and oncogenic mutants reveal structural oncogenic plasticity an...
https://doi.org/10.1073/pnas.2300054120
Proceedings of the National Academy of Sciences of the Un... Krimmer SG, Bertoletti N et. al.

Mar 22nd, 2023 - The receptor tyrosine kinase KIT and its ligand stem cell factor (SCF) are required for the development of hematopoietic stem cells, germ cells, and other cells. A variety of human cancers, such as acute myeloid leukemia, gastrointestinal stromal ...

Assessment of acute myeloid leukemia molecular measurable residual disease testing in a...
https://doi.org/10.1182/bloodadvances.2022009379
Blood Advances; Scott S, Dillon R et. al.

Mar 21st, 2023 - The European LeukaemiaNet (ELN) measurable residual disease (MRD) working group have published consensus guidelines to standardise molecular genetic MRD testing of the t(8;21)(q22;q22.1) RUNX1::RUNX1T1, inv(16)(p13.1q22) CBFB::MYH11, t(15;17)(q24....

see more →

Guidelines  13 results

NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021.
https://doi.org/10.6004/jnccn.2021.0002
Journal of the National Comprehensive Cancer Network : JN... Pollyea DA, Bixby D et. al.

Jan 7th, 2021 - The NCCN Guidelines for Acute Myeloid Leukemia (AML) provide recommendations for the diagnosis and treatment of adults with AML based on clinical trials that have led to significant improvements in treatment, or have yielded new information regard...

Hematopoietic Cell Transplantation in the Treatment of Newly Diagnosed Adult Acute Myel...
https://doi.org/10.1016/j.bbmt.2020.09.020
Biology of Blood and Marrow Transplantation : Journal of ... Dholaria B, Savani BN et. al.

Sep 24th, 2020 - The role of hematopoietic cell transplantation (HCT) in the management of newly diagnosed adult acute myeloid leukemia (AML) is reviewed and critically evaluated in this evidence-based review. An AML expert panel, consisting of both transplant and...

Clinical Practice Guideline for Systemic Antifungal Prophylaxis in Pediatric Patients W...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499615
Journal of Clinical Oncology : Official Journal of the Am... Lehrnbecher T, Fisher BT et. al.

May 28th, 2020 - To develop a clinical practice guideline for systemic antifungal prophylaxis in pediatric patients with cancer and hematopoietic stem-cell transplantation (HSCT) recipients. Recommendations were developed by an international multidisciplinary pane...

NCCN Guidelines Insights: Myeloproliferative Neoplasms, Version 2.2018.
https://doi.org/10.6004/jnccn.2017.0157
Journal of the National Comprehensive Cancer Network : JN... Mesa RA, Jamieson C et. al.

Oct 7th, 2017 - Myeloproliferative neoplasms (MPNs) are a group of heterogeneous disorders of the hematopoietic system that include myelofibrosis (MF), polycythemia vera (PV), and essential thrombocythemia (ET). PV and ET are characterized by significant thromboh...

Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology.
https://doi.org/10.6004/jnccn.2017.0116
Journal of the National Comprehensive Cancer Network : JN... O'Donnell MR, Tallman MS et. al.

Jul 9th, 2017 - Acute myeloid leukemia (AML) is the most common form of acute leukemia among adults and accounts for the largest number of annual deaths due to leukemias in the United States. This portion of the NCCN Guidelines for AML focuses on management and p...

see more →

Drugs  33 results see all →

Clinicaltrials.gov  1,760 results

Integrating Geriatric Assessment and Genetic Profiling to Personalize Therapy Selection in Older Adults With Acute Myeloid Leukemia
https://clinicaltrials.gov/ct2/show/NCT03226418

Mar 10th, 2023 - PRIMARY OBJECTIVES: I. To determine the rate of complete remission and mortality at 90 days in the entire cohort of older patients (>= 60 years) with newly diagnosed acute myeloid leukemia (AML) who receive clinicogenetic risk-stratified therapy a...

A Phase 1b Master Trial to Investigate CPX-351 in Subjects With Previously Untreated Acute Myeloid Leukemia
https://clinicaltrials.gov/ct2/show/NCT04075747

Mar 10th, 2023 - JZP025-101 is an open-label, multicenter, multi-arm, nonrandomized phase 1b master trial to determine the recommended phase 2 dose (RP2D) of CPX-351 when administered in combination with various targeted agents in previously untreated subjects wit...

Ruxolitinib in Patients With Myelofibrosis
https://clinicaltrials.gov/ct2/show/NCT05762874

Mar 10th, 2023 - Myelofibrosis (MF) is a clonal disorder of the pluripotent hematopoietic stem cell in which the abnormal stem cell population releases several cytokines and growth factors into the bone marrow microenvironment, it is pathologically characterized b...

Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome
https://clinicaltrials.gov/ct2/show/NCT05457556

Mar 10th, 2023 - PRIMARY OBJECTIVE: I. To compare the 1-year cumulative incidence of severe Graft Versus Host Disease (GVHD) (from day of HCT) defined as grade III-IV acute GVHD (aGVHD) and/or chronic GVHD (cGVHD) that requires systemic immunosuppression and to co...

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
https://clinicaltrials.gov/ct2/show/NCT05429632

Mar 10th, 2023 - The purpose of this study is to evaluate the efficacy and safety of mocravimod as an adjunctive and maintenance treatment in adult acute myeloid leukemia (AML) patients undergoing allogeneic hematopoietic cell transplantation (HCT).

see more →

News  2,666 results

Jimmy Carter's Melanoma; Post-Op Osimertinib Boosts OS; $83K for Unproven Therapy
https://www.medpagetoday.com/hematologyoncology/skincancer/103467

Mar 9th, 2023 - How the successful use of pembrolizumab (Keytruda) for former President Jimmy Carter's metastatic melanoma put "immunotherapy on the map." (Washington Post) A study of molecular changes observed in the breast tissue of transgender men undergoing a...

Maternal Infection May Play Role in Child's Leukemia
https://www.medpagetoday.com/hematologyoncology/leukemia/103182

Feb 20th, 2023 - Maternal genitourinary tract infections during pregnancy were linked to the development of leukemia in offspring, a Danish nationwide study found. Children born to a mother who experienced any kind of infection during pregnancy had increased risk ...

Toxin Exposure and Acute Myeloid Leukemia in Veterans
https://www.mdedge.com/fedprac/avaho/article/261111/conference-recap/service-related-toxin-exposure-and-acute-myeloid
Timothy O'Brien, MD

Feb 8th, 2023 - Members of the United States military who served in Vietnam between 1961 and 1971 risked exposure to the weaponized chemical defoliant known as Agent Orange. Among the components of Agent Orange, benzene and tetrachlorodibenzo-p-dioxin (TCDD) are.

ODAC to Review Lymphoma Drug; Tobacco Control; Artificial Skin Aids Cancer Studies
https://www.medpagetoday.com/hematologyoncology/lymphoma/102854

Jan 27th, 2023 - The FDA announced that the Oncologic Drugs Advisory Committee (ODAC) will meet March 9 to review the accelerated approval of polatuzumab vedotin (Polivy) plus rituximab (Rituxan) and chemotherapy for untreated diffuse large B-cell lymphoma. Jansse...

Rise in Cervical Cancer Mortality; Drug Active in Kids' Glioma; Vit D and Melanoma
https://www.medpagetoday.com/hematologyoncology/cervicalcancer/102634

Jan 13th, 2023 - A California study showed a concerning increase in cervical cancer mortality among women 65 or older, the age at which routine screening is no longer recommended. (UC Davis Comprehensive Cancer Center, Cancer Epidemiology, Biomarkers & Prevention)...

see more →

Patient Education  16 results see all →